Earlier, Fraser et al. (2005) demonstrated significant up-regulation of VGSCs in human breast cancer and proposed neonatal NaV1.5 as a novel marker for a metastatic phenotype and therapeutic target. The gene discussed is SCN5A; the disease is breast cancer.